In breast cancer RAO-3 cells, AKR1B10 interacts with acetyl-CoA carboxylase-α (a rate-limiting enzyme of de novo fatty acid synthesis), preventing acetyl-CoA carboxylase-α ubiquitination and proteolysis, and thereby promoting fatty acid/lipid synthesis [64]. This evidence concerns the gene AKR1B10 and breast carcinoma.